Exeltis Pharmaceuticals Holding SL:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Exeltis Pharmaceuticals Holding SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11339
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スペイン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exeltis Pharmaceuticals Holding SL (Exeltis), a subsidiary of Insud Pharma, is a developer, producer, and marketer of medicinal products and medical devices. The company provides products in the therapeutic areas including women’s health, dermatology, respiratory, central nervous system, infectious diseases, cardiology, ophthalmology, oncology, gastroenterology, and endocrinology, among others. It works in collaboration with healthcare professionals, patients, consumers, and other pharmaceutical companies, and health authorities to carry out its pharmacovigilence activities for identifying, assessing and reporting adverse reactions of marketed drugs. The company operates in France, Spain, Turkey, Switzerland, the US, among others. Exeltis is headquartered in Madrid, Spain.

Exeltis Pharmaceuticals Holding SL – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Exeltis Acquires Juste Farma Division from Juste labs 10
Licensing Agreements 11
Exeltis Enters into Licensing Agreement with Neurim Pharma 11
Grupo Juste Enters into Licensing Agreement with RedHill Biopharma and IntelGenx 12
D&A Pharma Enters into Licensing Agreement with Grupo JUSTE 13
Asset Transactions 14
Exeltis Acquires Juste Farma Division from Juste labs 14
Bial – Portela Acquires Business Unit from Grupo Juste 15
Acquisition 16
Exeltis Acquires Embil Pharma 16
Exeltis Acquires Althea Pharma 17
Exeltis Pharmaceuticals Holding SL – Key Competitors 18
Exeltis Pharmaceuticals Holding SL – Key Employees 19
Exeltis Pharmaceuticals Holding SL – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Key Facts 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exeltis Pharmaceuticals Holding SL, Deals By Therapy Area, 2012 to YTD 2018 8
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Exeltis Acquires Juste Farma Division from Juste labs 10
Exeltis Enters into Licensing Agreement with Neurim Pharma 11
Grupo Juste Enters into Licensing Agreement with RedHill Biopharma and IntelGenx 12
D&A Pharma Enters into Licensing Agreement with Grupo JUSTE 13
Exeltis Acquires Juste Farma Division from Juste labs 14
Bial - Portela Acquires Business Unit from Grupo Juste 15
Exeltis Acquires Embil Pharma 16
Exeltis Acquires Althea Pharma 17
Exeltis Pharmaceuticals Holding SL, Key Competitors 18
Exeltis Pharmaceuticals Holding SL, Key Employees 19
Exeltis Pharmaceuticals Holding SL, Other Locations 20
Exeltis Pharmaceuticals Holding SL, Subsidiaries 20

List of Figures
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Exeltis Pharmaceuticals Holding SL, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Exeltis Pharmaceuticals Holding SL:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Macquarie Group Ltd:企業の戦略・SWOT・財務分析
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Qiagen NV (QIA):企業の財務・戦略的SWOT分析
    Qiagen NV (QIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • UniQuest Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary UniQuest Pty Ltd (UniQuest), a subsidiary of The University of Queensland is a commercialization company that offers consultancy services. The company commercializes intellectual property and research outcomes of University of Queensland. It offers services such as eShop, witness, contract r …
  • Tillotts Pharma AG-製薬・医療分野:企業M&A・提携分析
    Summary Tillotts Pharma AG (Tillotts), a subsidiary of Zeria Pharmaceutical Co Ltd is a healthcare solution provider that develops, licenses and markets pharmaceutical products, medical devices and diagnostics in the field of gastroenterology. The company’s products are used for the treatment of var …
  • Engineers India Limited (ENGINERSIN):企業の財務・戦略的SWOT分析
    Engineers India Limited (ENGINERSIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Oriental Food Industries Holdings Berhad:企業の戦略・SWOT・財務情報
    Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report Summary Oriental Food Industries Holdings Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • United Therapeutics Corp (UTHR):医療機器:M&Aディール及び事業提携情報
    Summary United Therapeutics Corp (UTC) develops and commercializes innovative pharmaceutical products for the treatment of cardiovascular disorders, particularly pulmonary arterial hypertension and infectious diseases. The company's products consist of prostacyclin analogues including Remodulin (tre …
  • Statoil ASA (STL)-石油・ガス分野:企業M&A・提携分析
    Summary Statoil ASA (Statoil) is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets across the world, and trades crude oil and natural gas. The company operates assets in Norwegian Continental Shelf (NCS), which includes the North …
  • Dis-Chem Pharmacies Limited (DCP):企業の財務・戦略的SWOT分析
    Dis-Chem Pharmacies Limited (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Cytune Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Cytune Pharma SAS (Cytune) is a developer of immunotherapeutic agents for the treatment of cancer and infectious diseases. The company’s product portfolio includes recombinant proteins and monoclonal antibodies. Its CYP0150 is a recombinant protein, which decreases metastasis numbers, tumor …
  • Trivitron Healthcare Pvt Ltd:企業のM&A・事業提携・投資動向
    Trivitron Healthcare Pvt Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Trivitron Healthcare Pvt Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Selective Insurance Group, Inc. (SIGI):企業の財務・戦略的SWOT分析
    Selective Insurance Group, Inc. (SIGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Poslovni sistem Mercator, d.d.:企業のM&A・事業提携・投資動向
    Poslovni sistem Mercator, d.d. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Poslovni sistem Mercator, d.d. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • MedImmune LLC-製薬・医療分野:企業M&A・提携分析
    Summary MedImmune LLC (MedImmune), a subsidiary of AstraZeneca Plc, is a biotechnology company. It focuses on the research, development, manufacture and marketing of small molecules and biologics to address some of the major medical needs. The company develops therapeutic proteins, monoclonal antibo …
  • Municipal Energy Agency of Nebraska:発電所・企業SWOT分析
    Municipal Energy Agency of Nebraska – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Cboe Global Markets, Inc (CBOE):企業の財務・戦略的SWOT分析
    Cboe Global Markets, Inc (CBOE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Satair A/S:企業の戦略・SWOT・財務情報
    Satair A/S - Strategy, SWOT and Corporate Finance Report Summary Satair A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Skyworks Solutions Inc (SWKS):企業の財務・戦略的SWOT分析
    Skyworks Solutions Inc (SWKS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • AB SKF (SKF B)-エネルギー分野:企業M&A・提携分析
    Summary AB SKF (SKF) is a manufacturer and supplier of bearing and seal products that include ball bearings, roller bearings, bearing accessories, truck runner bearings, super-precision bearings, plain bearings, bearing units, bearing housings, and automotive and industrial seal. SKF also offers lub …
  • Tahoe Resources Inc.:企業の戦略・SWOT・財務情報
    Tahoe Resources Inc. - Strategy, SWOT and Corporate Finance Report Summary Tahoe Resources Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆